SFU
NEO icon

Stonehage Fleming (UK)’s NeoGenomics NEO Stock Holding History

Stonehage Fleming (UK)’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,530
Closed -$19K – 238
2014
Q4 		$19K Buy
4,530
+641
+16% +$2.94K 0.01% 259
2014
Q3 		$20K Buy
+3,889
New +$20K 0.01% 252

Other funds holding NEO

CRC
Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

Stonehage Fleming (UK)'s NEO Position: Q1 2015 in Review

Stonehage Fleming (UK) sold out of NeoGenomics (NEO) in Q1 2015, closing a stake of 4,530 shares — an estimated $19K sold.

Stonehage Fleming (UK) first reported a position in NEO in Q3 2014 and held it in 2 quarters. The position peaked at $20K in Q3 2014. 84 funds tracked by Wall St. Rank hold NEO as of Q1 2015.

  • Stonehage Fleming (UK) reported no remaining NeoGenomics position as of Q1 2015 after selling out during the quarter.
  • Stonehage Fleming (UK) sold 4,530 NeoGenomics shares in Q1 2015, an estimated $19K.
  • Stonehage Fleming (UK) first reported a position in NeoGenomics in Q3 2014 and held it in 2 quarters.
  • Stonehage Fleming (UK)'s NeoGenomics position peaked at $20K in Q3 2014.
  • 84 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q1 2015, filed 11 Oct 2019.